1. Home
  2. JAGX vs PRSO Comparison

JAGX vs PRSO Comparison

Compare JAGX & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • PRSO
  • Stock Information
  • Founded
  • JAGX 2013
  • PRSO 2008
  • Country
  • JAGX United States
  • PRSO United States
  • Employees
  • JAGX N/A
  • PRSO N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • PRSO Semiconductors
  • Sector
  • JAGX Health Care
  • PRSO Technology
  • Exchange
  • JAGX Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • JAGX 3.1M
  • PRSO 3.3M
  • IPO Year
  • JAGX N/A
  • PRSO 2001
  • Fundamental
  • Price
  • JAGX $4.46
  • PRSO $0.58
  • Analyst Decision
  • JAGX
  • PRSO Strong Buy
  • Analyst Count
  • JAGX 0
  • PRSO 2
  • Target Price
  • JAGX N/A
  • PRSO $3.38
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • PRSO 69.3K
  • Earning Date
  • JAGX 03-31-2025
  • PRSO 05-12-2025
  • Dividend Yield
  • JAGX N/A
  • PRSO N/A
  • EPS Growth
  • JAGX N/A
  • PRSO N/A
  • EPS
  • JAGX N/A
  • PRSO N/A
  • Revenue
  • JAGX $11,689,000.00
  • PRSO $14,573,000.00
  • Revenue This Year
  • JAGX $18.18
  • PRSO $3.74
  • Revenue Next Year
  • JAGX $40.06
  • PRSO $37.09
  • P/E Ratio
  • JAGX N/A
  • PRSO N/A
  • Revenue Growth
  • JAGX 19.75
  • PRSO 5.99
  • 52 Week Low
  • JAGX $4.40
  • PRSO $0.60
  • 52 Week High
  • JAGX $540.00
  • PRSO $2.34
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.11
  • PRSO 28.79
  • Support Level
  • JAGX $4.41
  • PRSO $0.68
  • Resistance Level
  • JAGX $4.97
  • PRSO $0.94
  • Average True Range (ATR)
  • JAGX 0.74
  • PRSO 0.07
  • MACD
  • JAGX 0.22
  • PRSO -0.02
  • Stochastic Oscillator
  • JAGX 3.95
  • PRSO 0.56

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: